Dr Daniel Martins is a Clinical Research Associate, Dr Mattia Veronese is a senior molecular imaging scientist and Dr. Ottavia Dipasquale is a Research Associate, all in the Department of Neuroimaging at King’s College London. In this blog they discuss their recent study which is funded by the NIHR Maudsley BRC and has brought together scientists from across the world to define a new approach to integrate neuroimaging and a form of genetic mapping.
By
NIHR Maudsley BRC at 21 Jan 2022
A clinical trial that is collecting data on the features of opioid overdoses within the safety of a clinical setting will be integrating a monitoring platform into the research to investigate how to prevent deaths from breathing problems in opioid users.
By
NIHR Maudsley BRC at 20 Jan 2022
Naghmeh Nikkheslat is a Senior Research Associate at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) who is working on a project funded by the NIHR Maudsley BRC to investigate the use of ketamine as a medication for depression. In this blog, she talks about her research into depression and the immune system and what we currently know about ketamine as an anti-inflammatory antidepressant in psychiatric emergencies.
By
NIHR Maudsley BRC at 10 Jan 2022
Researchers from King’s College London and South London and Maudsley NHS Foundation Trust have shown that there are variations in how a brain chemical called GABA regulates the processing of visual stimuli. The study showed that when autistic people are given a drug that activates GABA targets, their visual processing becomes more like that of non-autistic people.
By
NIHR Maudsley BRC at 6 Jan 2022
New research from King’s College London, in partnership with COMPASS Pathways and supported by NIHR Maudsley BRC, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants at the same time.
By
NIHR Maudsley BRC at 4 Jan 2022
